Bibliotecas PUC-SP - Busca Integrada

Novel Tools for Diagnosis and Monitoring of AML

Por Francesca Guijarro, Marta Garrote, Neus Villamor, Dolors Colomer, Jordi Esteve, Mónica López-Guerra
Publicado no Current Oncology (2023-05-01)

Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia

Por Laia Cuesta-Casanovas, Jennifer Delgado-Martínez, Josep M. Cornet-Masana, José M. Carbó, Antònia Banús-Mulet, Francesca Guijarro, Jordi Esteve, Ruth M. Risueño
Publicado no Cancer Cell International (2023-05-01)

Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cellsResearch in context

Por Josep M. Cornet-Masana, Antònia Banús-Mulet, José M. Carbó, Miguel Ángel Torrente, Francesca Guijarro, Laia Cuesta-Casanovas, Jordi Esteve, Ruth M. Risueño
Publicado no EBioMedicine (2019-09-01)

Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing

Por Marta Garrote, Mónica López-Guerra, Eduardo Arellano-Rodrigo, María Rozman, Sara Carbonell, Francesca Guijarro, Marta Santaliestra, Ana Triguero, Dolors Colomer, Francisco Cervantes, Alberto Álvarez-Larrán
Publicado no Cancers (2023-07-01)

P1054: CLINICAL CHARACTERISTICS AND OUTCOMES IN 175 PATIENTS WITH MYELOFIBROSIS ACCORDING TO GENOMIC CLASSIFICATION USING NEXT-GENERATION SEQUENCING

Por Marta Garrote Ordeig, Monica Lopez-Guerra, Eduardo Arellano-Rodrigo, Maria Rozman, Sara Carbonell Ordeig, Francesca Guijarro, Marta Santaliestra Tomas, Ana Triguero Moreno, Dolors Colomer, Francisco Cervantes, Alberto Alvarez Larran
Publicado no HemaSphere (2023-08-01)

P532: KINETICS AND PROGNOSTIC VALUE OF MEASURABLE RESIDUAL DISEASE (MRD) IN PATIENTS DIAGNOSED WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH VENETOCLAX IN COMBINATION WITH HYPOMET...

Por Carlos Jimenez-Vicente, Francesca Guijarro, Monica Lopez-Guerra, Ares Guardia-Torrelles, Alexandra Martínez Roca, Alex Bataller, Daniel Esteban, Albert Cortés, Inés Zugasti, Daniel Munarriz, Dolors Colomer, Marina Diaz-Beya, Jordi Esteve
Publicado no HemaSphere (2023-08-01)

PB1846: MANAGEMENT OF PATIENTS TREATED WITH VENETOCLAX WITH HYPOMETHYLATING AGENTS: LONG-TERM INCIDENCE OF CYTOPENIAS AND INFECTIONS

Por Ares Guardia-Torrelles, Carlos Jimenez-Vicente, Alexandra Martínez Roca, Sandra Castaño-Díez, Helena Brillembourg, Francesca Guijarro, Àlex Bataller, Daniel Esteban, Albert Cortés, Inés Zugasti, Daniel Munarriz, Marina Diaz-Beya, Jordi Esteve, Beatriz Merchan
Publicado no HemaSphere (2023-08-01)

CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases

Por Laura González-Guerrero, Helena Castellet, Clara Martínez, Nuria González, Francesca Guijarro, Natalia Lloveras, Marta Pratcorona, Ignasi Gich, Pau Berenguer-Molins, Júlia Perera-Bel, Lurdes Zamora, Martí Mascaró, Antonia Sampol, Antoni Garcia-Guiñón, Susana Vives, Mar Tormo, Montserrat Arnan, Neus Villamor, Josep F. Nomdedéu
Publicado no Diagnostic Pathology (2025-04-01)

Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes

Por Sandra Castaño-Díez, Mónica López-Guerra, Cristina Bosch-Castañeda, Alex Bataller, Paola Charry, Daniel Esteban, Francesca Guijarro, Carlos Jiménez-Vicente, Carlos Castillo-Girón, Albert Cortes, Alexandra Martínez-Roca, Ana Triguero, José Ramón Álamo, Silvia Beà, Dolors Costa, Dolors Colomer, María Rozman, Jordi Esteve, Marina Díaz-Beyá
Publicado no Cancers (2022-08-01)

Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia

Por Carlos Jiménez-Vicente, Iago Arribas, Helena Pomares, Guillermo Ramil, Sandra Castaño-Diez, Amanda Isabel Pérez-Valencia, Antonella Luciana Sturla, Mònica López-Guerra, Alexandra Martinez-Roca, Inés Zugasti, Francesca Guijarro, Albert Cortés-Bullich, Beatriz Merchán, Ana Triguero, Inés Monge, Albert Tuca, Guadalupe Oñate, Ana Garrido, Jorge Sierra, Montserrat Arnan, Jordi Esteve, Marina Díaz-Beyá, Spanish CETLAM Group
Publicado no Haematologica (2025-01-01)

P1356: CD84-TARGETED CART-CELL THERAPY: A NOVEL STRATEGY FOR THE TREATMENT OF HAEMATOLOGICAL MALIGNANCIES

Por Lorenza Pérez Amill, Mercedes Armand Ugon, Sergio Peña Pérez, Maria Val Casals, Claudio Santos, Gerard Frigola, José Ramon Álamo, Francesca Guijarro, Alfredo Minguela, Àlex Bataller, Juan Gonzalo Correa Saldarriaga, Berta Casanovas Albertí, Mireia Uribe Herranz, Europa Azucena Gonzalez, Daniel Benitez-Ribas, Diego Sanchez, Nestor Tirado, Paola Romecin, Talía Velasco, Pablo Menendez, Antonio Martínez, Montserrat Rovira Tarrats, Jordi Esteve, Avaro Urbano Ispizua, Julio Delgado, Manel Juan, Nela Klein González
Publicado no HemaSphere (2023-08-01)

Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the...

Por Carlos Jimenez-Vicente, Aina Cardus, Sandra Castaño-Diez, Guillermo Ramil, Sara Garcia-Avila, Lucia Gomez-Perez, Daniel Esteban, Iago Arribas, Antonella Lucia Sturla, Monica Lopez-Guerra, Alexandra Martinez-Roca, Albert Cortes-Bullich, Amanda Isabel Perez-Valencia, Ines Zugasti, Ines Monge, Esther Carcelero, Ferran Vall-Llovera, Susana Vives, Jorge Sierra, Josep Nomdedeu, Guadalupe Oñate, Ana Garrido, Marta Pratcorona, Helena Pomares, Montserrat Arnan, Francesca Guijarro, Marina Diaz-Beya, Jordi Esteve, on behalf of the Spanish CETLAM Group
Publicado no Blood Cancer Journal (2025-05-01)

Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study

Por Ines Zugasti, Monica Lopez-Guerra, Sandra Castaño-Díez, Daniel Esteban, Alejandro Avendaño, Helena Pomares, Ana Perez, Sara García-Ávila, Irene Padilla Conejo, Cristina de la Fuente Montes, Alexandra Martínez-Roca, Beatriz Merchán, Carlos Jiménez-Vicente, Francesca Guijarro, Jose Ramón Álamo, Albert Cortes-Bullich, Victor Torrecillas, Lucia Mont, Esther Carcelero, Gisela Riu, Lurdes Zamora, Joan Bargay, Ana Triguero, Maria Suarez-Lledó, Maria Queralt Salas, Felix López-Cadenas, Fernando Ramos, Blanca Xicoy, David Valcárcel, Montserrat Arnan, Carmen Martínez, Montserrat Rovira, Francesc Fernández-Avilés, Maria Díez-Campelo, Jordi Esteve, Marina Díaz-Beyá
Publicado no Experimental Hematology & Oncology (2025-04-01)

<i>BCL3</i> rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases

Por Anna Carbo-Meix, Francesca Guijarro, Luojun Wang, Marta Grau, Romina Royo, Gerard Frigola, Heribert Playa-Albinyana, Marco M. Buhler, Guillem Clot, Marti Duran-Ferrer, Junyan Lu, Isabel Granada, Maria-Joao Baptista, Jose-Tomas Navarro, Blanca Espinet, Anna Puiggros, Gustavo Tapia, Laura Bandiera, Gabriella De Canal, Emanuela Bonoldi, Fina Climent, Inmaculada Ribera-Cortada, Mariana Fernandez-Caballero, Esmeralda de la Banda, Janilson do Nascimento, Alberto Pineda, Dolors Vela, Maria Rozman, Marta Aymerich, Charlotte Syrykh, Pierre Brousset, Miguel Perera, Lucrecia Yanez, Jesus Xavier Ortin, Esperanza Tuset, Thorsten Zenz, James R. Cook, Steven H. Swerdlow, Jose I. Martin-Subero, Dolors Colomer, Estella Matutes, Silvia Bea, Dolors Costa, Ferran Nadeu, Elias Campo
Publicado no Haematologica (2023-08-01)